微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.26% | -49.8% | -80.06% | 63/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 6.32% | 91.52% | 1.94% | 45/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.2% | 39.01% | 80.23% | 43/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.44% | 45.76% | 37.05% | 51/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.51% | 41.01% | -23.94% | 32/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.3% | -63.7% | -26.01% | 75/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.46% | -55.67% | 88.98% | 62/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.36% | -70.28% | 32.58% | 71/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.78% | -69.2% | -80.42% | 56/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.09% | -75.8% | -9.64% | 40/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 10.06% | -75.44% | 26.7% | 26/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7.94% | -69.15% | 37.37% | 17/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.78% | 2% | -84.61% | 9/139 | 2.28% | XD安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 37.56% | 18.94% | -8.3% | 9/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 40.96% | 2% | 59.13% | 7/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 25.74% | 52.13% | -18.49% | 11/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 31.58% | -61.3% | 86.64% | 15/139 | 17.28% | 九安医疗 | 142.71% | 行业排名> |
| 2021-06-30 | 16.92% | -77.39% | -79.27% | 18/139 | 11.46% | 热景生物 | 121.78% | 行业排名> |
| 2020-12-31 | 81.61% | 122.49% | 9.08% | 12/139 | 25.47% | 热景生物 | 99.69% | 行业排名> |
| 2020-06-30 | 74.82% | 2% | 103.98% | 3/139 | 15.03% | 热景生物 | 99.09% | 行业排名> |
| 2019-12-31 | 36.68% | 87.24% | 87.24% | 6/139 | 14.24% | 热景生物 | 57.63% | 行业排名> |
| 2018-12-31 | 19.59% | 620.22% | 620.22% | 33/139 | 12.87% | 中红医疗 | 168% | 行业排名> |
| 2017-12-31 | 2.72% | 2% | 2% | 89/139 | 13.76% | 圣湘生物 | 112.46% | 行业排名> |